Sumatriptan, a selective 5-HT1B/1D receptor agonist, acts by constricting cerebral blood vessels and inhibiting neurogenic inflammation in cluster headache treatment. By binding to serotonin receptors in the cranial vasculature, it reduces pain transmission and alleviates acute headache symptoms through central and peripheral mechanisms of action.